1-6 of 6
Michael P. Rettig
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization

Daniel Cancilla, Michael P. Rettig, Darja Karpova, Haresh Thakellapalli, Megh Singh, Marvin J. Meyers, Peter G. Ruminski, Stephanie Christ, Ezhilarasi Chendamarai, Feng Gao, Leah Gehrs, Julie K. Ritchey, Michael Prinsen, John F. DiPersio
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1379–1383.
https://doi.org/10.1182/bloodadvances.2023011653
Published: 2024
Includes: Supplemental data
Journal Articles

Blinatumomab consolidation post–autologous stem cell transplantation in patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
Armin Ghobadi, Nicole C. Foley, Jared Cohen, Michael P. Rettig, Amanda F. Cashen, Leah Gehrs, Stephanie Christ, Emily Street, Nicholas Wallace, Julie Ritchey, Neha Mehta-Shah, Peter Westervelt, Todd A. Fehniger, Brad Kahl, Nancy L. Bartlett, John F. DiPersio
Journal: Blood Advances
Blood Adv (2024) 8 (3): 513–522.
https://doi.org/10.1182/bloodadvances.2023011130
Published: 2024
Includes: Supplemental data
Journal Articles

Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor

Clinical Trials & Observations
Zachary D. Crees, Michael P. Rettig, Asad Bashey, Steven M. Devine, Samantha Jaglowski, Fei Wan, Amy Zhou, Melinda Harding, Abi Vainstein-Haras, Ella Sorani, Irit Gliko-Kabir, Brenda J. Grossman, Peter Westervelt, John F. DiPersio, Geoffrey L. Uy
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5210–5214.
https://doi.org/10.1182/bloodadvances.2023010407
Published: 2023
Includes: Supplemental data
Journal Articles

Machine learning–based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors

Jingyu Xiang, Min Shi, Mark A. Fiala, Feng Gao, Michael P. Rettig, Geoffrey L. Uy, Mark A. Schroeder, Katherine N. Weilbaecher, Keith E. Stockerl-Goldstein, Shamim Mollah, John F. DiPersio
Journal: Blood Advances
Blood Adv (2022) 6 (7): 1991–2000.
https://doi.org/10.1182/bloodadvances.2021005149
Published: 2022
Includes: Supplemental data
Journal Articles

TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

Clinical Trials & Observations
Jayakumar Vadakekolathu, Catherine Lai, Stephen Reeder, Sarah E. Church, Tressa Hood, Anbarasu Lourdusamy, Michael P. Rettig, Ibrahim Aldoss, Anjali S. Advani, John Godwin, Matthew J. Wieduwilt, Martha Arellano, John Muth, Tung On Yau, Farhad Ravandi, Kendra Sweet, Heidi Altmann, Gemma A. Foulds, Friedrich Stölzel, Jan Moritz Middeke, Marilena Ciciarello, Antonio Curti, Peter J. M. Valk, Bob Löwenberg, Ivana Gojo, Martin Bornhäuser, John F. DiPersio, Jan K. Davidson-Moncada, Sergio Rutella
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5011–5024.
https://doi.org/10.1182/bloodadvances.2020002512
Published: 2020
Includes: Supplemental data
Journal Articles

Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient

Clinical Trials & Observations
Aabha Oza, Michael P. Rettig, Phil Powell, Kathryn O’Brien, David B. Clifford, Julie Ritchey, Leah Gehrs, Julia Hollaway, Eugene Major, Todd A. Fehniger, Christopher A. Miller, Patrick Soon-Shiong, Amy Rock, John F. DiPersio
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2387–2391.
https://doi.org/10.1182/bloodadvances.2019000664
Published: 2020